AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zetaglim M 3mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Elinor Pharmaceuticals Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Zetaglim M 3mg/500mg Tablet SR

Metformin/Linagliptin 3mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose control. These tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as premature discontinuation, without medical consultation, risks elevated glucose levels and potential complications such as kidney impairment, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan, including a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by symptoms like sweating, lightheadedness, headache, and tremors. Prompt glucose replenishment (e.g., sugary foods or juice) is vital; maintain regular mealtimes and carry a rapid-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended by your physician.

Uses of Zetaglim M 3mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Zetaglim M 3mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. The Zetaglim M 3mg/500mg sustained-release tablet should be administered with a meal.

Common Side effects of Zetaglim M 3mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Zetaglim M 3mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet; do not chew, crush, or fracture it. Consume Zetaglim M 3mg/500mg SR tablets with a meal.

How Zetaglim M 3mg/500mg Tablet SR works:

Zetaglim M 3mg/500mg Extended-Release tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Zetaglim M 3mg/500mg SR tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zetaglim M 3mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Zetaglim M 3mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Caution is advised when prescribing Zetaglim M 3mg/500mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Patients with severely compromised kidney function should not use Zetaglim M 3mg/500mg SR tablets. Regular monitoring of renal function is recommended during treatment. Physician consultation is recommended.

LiverLiverCAUTION

Caution is advised when prescribing Zetaglim M 3mg/500mg SR tablets to individuals with hepatic impairment. Dosage modification of Zetaglim M 3mg/500mg SR tablets may be necessary. Physician consultation is recommended. For patients exhibiting mild to moderate liver dysfunction, initiation of Zetaglim M 3mg/500mg SR tablets should generally begin with a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Zetaglim M 3mg/500mg Tablet SR :

Should you forget to take your Zetaglim M 3mg/500mg SR Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Zetaglim M 3mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Zetaglim M 3mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Zetaglim M 3mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Zetaglim M 3mg/500mg Tablet SR and seek immediate medical attention.
Zetaglim M 3mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Zetaglim M 3mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Zetaglim M 3mg/500mg SR tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Zetaglim M 3mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Zetaglim M 3mg/500mg SR tablets and alcohol is unsafe. Alcohol can worsen low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Zetaglim M 3mg/500mg Tabl...
113
MRP 138
18% off